Denali therapeutics inc. (DNLI)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Assets
Current assets:
Cash and cash equivalents

207,537

79,449

82,673

62,936

39,661

77,123

43,651

33,088

44,001

218,375

Short-term marketable securities

379,713

335,907

396,717

415,667

445,820

387,174

331,307

339,503

329,401

187,851

Prepaid expenses and other current assets

17,535

14,675

14,987

17,378

14,052

16,539

8,445

4,827

4,020

3,381

Total current assets

604,785

430,031

494,377

495,981

499,533

480,836

383,403

377,418

377,422

409,607

Long-term marketable securities

9,684

39,886

23,534

55,832

97,554

147,881

142,173

178,703

219,406

60,750

Property and equipment, net

45,452

46,732

47,481

47,195

36,955

25,162

16,245

13,323

14,860

14,923

Operating lease right-of-use asset

33,626

33,923

34,300

34,600

34,400

-

-

-

-

-

Other non-current assets

2,318

2,659

3,242

3,949

8,147

8,105

2,654

2,611

2,265

1,441

Total assets

695,865

553,231

602,978

637,604

676,596

661,984

544,475

572,055

613,953

486,721

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

2,316

2,590

2,022

3,931

3,662

1,891

3,354

9,176

1,377

2,716

Accrued compensation

3,910

8,739

7,528

4,092

3,213

-

4,847

2,751

1,994

5,166

Accrued clinical costs

5,349

5,042

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

3,227

4,782

874

855

Accrued expenses and other current liabilities

-

-

3,483

2,135

1,107

19,468

138

47

63

63

Other accruals and other current liabilities

7,265

6,569

15,467

13,793

12,114

-

7,393

5,537

4,425

5,364

Operating lease liability, current

4,121

3,665

-

-

-

-

-

-

-

-

Contract liabilities

24,674

18,739

18,185

22,598

23,148

11,427

12,658

8,715

8,434

0

Total current liabilities

47,635

45,344

46,685

46,549

43,244

32,786

31,617

31,008

17,167

14,164

Contract liabilities, less current portion

34,747

43,753

47,795

44,563

44,852

57,350

44,452

49,590

51,519

0

Operating lease liability, less current portion

67,793

68,865

69,900

70,900

71,400

-

-

-

-

-

Deferred rent, less current portion

-

-

-

-

-

24,532

7,103

1,029

6,051

6,294

Other non-current liabilities

379

379

386

408

440

471

124

156

188

467

Total liabilities

150,554

158,341

164,781

162,431

159,948

115,139

83,296

81,783

74,925

20,925

Commitments and contingencies (Note 8)

-

-

-

-

-

-

0

0

0

-

Stockholders' equity:
Convertible preferred stock, $0.01 par value; 40,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 0 shares issued and outstanding as of March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

Common stock, $0.01 par value; 400,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 105,541,343 shares and 96,189,935 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

1,382

1,288

1,286

1,283

1,279

1,273

1,266

1,259

1,252

1,201

Additional paid-in capital

1,025,408

818,803

807,875

798,277

781,966

774,158

766,799

760,605

754,438

656,660

Accumulated other comprehensive income

835

350

562

879

332

-649

-1,416

-1,493

-1,287

-368

Accumulated deficit

-482,314

-425,551

-371,526

-325,266

-266,929

-227,937

-305,470

-270,099

-215,375

-191,697

Total stockholders' equity

545,311

394,890

438,197

475,173

516,648

546,845

461,179

490,272

539,028

465,796

Total liabilities and stockholders’ equity

695,865

553,231

602,978

637,604

676,596

661,984

544,475

572,055

613,953

486,721